Trails Edge Capital Partners »

Research Alliance Corp Iii shares owned by Trails Edge Capital Partners

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by Trails Edge Capital Partners from 13F filings

Historical chart of Trails Edge Capital Partners investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by Trails Edge Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by Trails Edge Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.4M 500k 10.70

More positions owned by Trails Edge Capital Partners

Lb Pharmaceuticals Com Shs (LBRX)
Nurix Therapeutics (NRIX)
Immunocore Hldgs Ads (IMCR)
First Tracks Biotherapeutics Ord Shs (TRAX)
4d Molecular Therapeutics In (FDMT)
BioMarin Pharmaceutical (BMRN)
Design Therapeutics (DSGN)
Xenon Pharmaceuticals (XENE)
Mirum Pharmaceuticals (MIRM)
Insmed Com Par $.01 (INSM)
Cytokinetics Com New (CYTK)
Syndax Pharmaceuticals (SNDX)
Neurogene (NGNE)
Kailera Therapeutics Common Stock
Revolution Medicines (RVMD)

View all positions for Trails Edge Capital Partners

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii